Anti-tumor necrosis factor-alpha treatment for Lyme borreliosis.
McSweegan
Edward
E
D000818:Animals; D025065:Borrelia burgdorferi / Q000187:drug effects* / Q000472:pathogenicity; D002443:Ceftriaxone / Q000494:pharmacology; D008193:Lyme Disease / Q000188:drug therapy* / Q000382:microbiology; D051379:Mice; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors* / Q000276:immunology
D014409:Tumor Necrosis Factor-alpha; D002443:Ceftriaxone